Clinical Trial Update: Intralipid Therapy for Women 35-40 Years With Positive Natural Killer Cells Undergoing Intracytoplasmic Sperm Injection (ICSI) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of intralipid therapy for infertility in women 35-40 with positive natural killer cells undergoing ICSI has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Intralipid (intravenous lipid emulsion)

Snippet

Sponsor: Cairo University | Conditions: Infertility | Phase 3 | Status: TERMINATED